Kevin Brunet is currently leading the Device Devlopment and Primary Packaging Quality group at UCB.
During the last 12 years, he has developed a strong expertise in the development and manufacturing of Medical Devices and Drug-device combination products with roles in R&D, Supply chain, Operations and Quality.
His main expertise lays within Design and Development, Risk Management, Supplier Audits and Management with track records of innovative products brought to approval and launch (including N.B. Audits and H.A. Inspections).

Bjarne Sørensen is a director of front-end innovation at Phillips Medisize, based in the company’s development centre in Denmark. With more than 35 years of experience within product, strategy, and business development, Bjarne has a very visible track record within different business areas. At Phillips Medisize, he participates in customer projects, typically involving electronic injectors and connected health systems. He is also deeply involved in new electronic platform programs, especially on conceptual, technical, and sustainability aspects.

With over a decade of experience in regulatory and quality strategy for medical devices, drug-device combination products, and clinical research, a strong record of contributing to successful global product approvals (FDA, EMA, TGA, PMDA, and others) has been established through collaborative and innovative approaches. Successful support of high-stakes submissions—including NDA, BLA, MAA, JNDA, STED, MAF, and NBoP—has been achieved alongside cross-functional teams, enabling the development and commercialization of complex products. Experience includes building effective partnerships with CROs, CMOs, and global stakeholders, as well as active participation in industry discussions that help shape best practices and regulatory policy. Excellence is pursued through teamwork, shared success, and a commitment to advancing the regulatory field.